NCT06170411View on ClinicalTrials.gov

Post-marketing Clinical Trial of Elexir(Trigeminal Nerve Electrical Stimulator) for the Acute Treatment of Migraine

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 27, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
Migraine
Interventions
DEVICE

Elexir (program1)

The Elexir is an external cranial neurostimulator designed for supraorbital neurostimulation, also known as Trigeminal Nerve Stimulation. The Elexir will deliver trigeminal nerve stimulation.

DEVICE

sham device

The sham device will deliver sham trigeminal nerve stimulation.

Trial Locations (2)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si

All Listed Sponsors
lead

Nu Eyne Co., Ltd.

INDUSTRY